Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
about
Stem cell transplantation in chronic lymphocytic leukemiaHematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimensDoes total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.Haematopoietic stem cell transplantation: indications, clinical developments and future directions.Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?The role of allogeneic transplantation in non-Hodgkin's lymphoma.The graft-versus-lymphoma effect: clinical review and future opportunities.Revisiting the role of hematopoietic stem cell transplantation in chronic lymphocytic leukemia.Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningQualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemia.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.Fight fire with fire: Gene therapy strategies to cure HIV.Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study.High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia.Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.Hematopoietic stem cell transplantation for hematological malignancies in Europe.Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies.
P2860
Q24642921-06558A93-7EED-4DCD-BA93-1F4CDA1C7590Q27021206-A9D26172-1E3F-4764-BAD2-FA5024F32E5FQ30407633-50DB263F-58F8-4584-B2D1-BB9B256B966EQ34197491-5073EBAA-3245-4267-99FF-943125D31400Q34240410-353EAF89-6894-4B1D-912E-C2FF7CD2AA5DQ34449575-37084991-3608-490A-93F7-4C9577DDA382Q35116184-46C847CC-DA35-4EE9-BDF2-313301137D50Q35609690-C271CC95-A780-4FC7-8E57-3242D9A8F2B4Q35819325-1059F55C-71FD-40FA-B9D8-7E6E20E821AAQ36003103-F8FDA1E9-18F6-447A-B8C0-3EA26D8D83F8Q36128232-9AC7C3F2-060F-40A2-B023-8A92A7E27572Q36284521-1A4AC133-4C05-48C5-9EB0-5552ACD64B5CQ37119402-BD309F05-2B64-48F1-AA8C-E7614D135A60Q37175581-78AF1C7D-407F-41A1-9A54-CE67D7ABB9ABQ37824996-714D44ED-B583-4E76-A913-339521A970CFQ38007853-8DA8D6E0-6620-4FD4-9E27-8374A448C579Q38355743-C8495A9A-DF0C-4870-9243-C3069BD4D4A6Q38962267-BDF32D25-2449-4C51-A5A2-376FAE9A1DF8Q39425614-F99458A2-0FFE-4DA9-92DC-0DC2ABE2E231Q39996013-DDF6D682-7B5A-4E56-B446-A48B1E3C596EQ44580107-D3DFE632-205A-4B83-9498-2912C59827BEQ46061825-128BFEE1-41E6-47A6-8F2A-2F5C7E33BAC0Q47677806-173754D2-B126-4DEC-80DE-04E1F1F15409Q47908471-7BDBF5E0-7B5B-4611-82FE-DDF953247A40Q53453511-61C11BDC-A9DE-4D09-9F67-91E4A4626A4FQ53538542-37EEB1B9-77FE-495B-B788-195345C220E3
P2860
Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@en
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@nl
type
label
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@en
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@nl
prefLabel
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@en
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P356
P1476
Allogeneic related donor hemat ...... chronic lymphocytic leukemia.
@en
P2093
Seattle Bone Marrow Transplant Team
T Chauncey
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703548
P407
P577
2002-05-01T00:00:00Z